Change in plasma acylation stimulating protein during euglycaemic- hyperinsulinaemic clamp in overweight and obese postmenopausal women: A MONET study

Clinical Endocrinology

Volumn 70, Issue 4, 2009, Pages 539-546

  St Pierre, David H ^a,e   Cianflone, Katherine ^b   Smith, Jessica ^b   Coderre, Lise ^a   Karelis, Antony D ^a,c   Imbeault, Pascal ^d   Lavoie, Jean Marc ^a   Rabasa Lhoret, Rémi ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION STIMULATING PROTEIN; ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AEROBIC CAPACITY; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENERGY EXPENDITURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIVER FUNCTION; MAJOR CLINICAL STUDY; METABOLIC RATE; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOCYTES; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BASAL METABOLISM; BODY COMPOSITION; BODY MASS INDEX; COMPLEMENT C3; ENERGY METABOLISM; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; INSULIN; MIDDLE AGED; OBESITY; OVERWEIGHT; OXYGEN CONSUMPTION; POSTMENOPAUSE; PROSPECTIVE STUDIES; QUEBEC;

EID: 61449242893     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03353.x     Document Type: Article

References (44)

1. Brochu, M., Tchernof, A., Dionne, I.J. et al. (2001) What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? Journal of Clinical Endocrinology and Metabolism, 86, 1020 1025.
2. Cote, M., Mauriege, P., Bergeron, J. et al. (2005) Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. Journal of Clinical Endocrinology and Metabolism, 90, 1434 1439.
3. Dube, M.C., Joanisse, D.R., Prud'homme, D. et al. (2006) Muscle adiposity and body fat distribution in type 1 and type 2 diabetes: varying relationships according to diabetes type. International Journal of Obesity, 30, 1721 1728.
4. Wheeler, G.L., Shi, R., Beck, S.R. et al. (2005) Pericardial and visceral adipose tissues measured volume trically with computed tomography are highly associated in type 2 diabetic families. Investigative Radiology, 40, 97 101.
5. Kalant, D., Cain, S.A., Maslowska, M. et al. (2003) The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. Journal of Biological Chemistry, 278, 11123 11129.
6. Cianflone, K., Xia, Z. Chen, L.Y. (2003) Critical review of acylation-stimulating protein physiology in humans and rodents. Biochemica Biophysica Acta, 1609, 127 143.
7. Maslowska, M., Wang, H.W. Cianflone, K. (2005) Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence. Vitamins and Hormones, 70, 309 332.
8. Saleh, J., Blevins, J.E., Havel, P.J. et al. (2001) Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents. International Journal of Obesity and Related Metabolic Disorders, 25, 705 713.
9. Cortez-Pinto, H., Camilo, M.E., Baptista, A. et al. (1999) Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clinical Nutrition, 18, 353 358.
10. Lam, T.K., Carpentier, A., Lewis, G.F. et al. (2003) Mechanisms of the free fatty acid-induced increase in hepatic glucose production. American Journal of Physiology Endocrinology and Metabolism, 284, E863 E873.
11. Cianflone, K., Kalant, D., Marliss, E.B. et al. (1995) Response of plasma ASP to a prolonged fast. International Journal of Obesity and Related Metabolic Disorders, 19, 604 609.
12. Koistinen, H.A., Vidal, H., Karonen, S.L. et al. (2001) Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 1034 1039.
13. Maslowska, M., Vu, H., Phelis, S. et al. (1999) Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. European Journal of Clinical Investigations, 29, 679 686.
14. Weyer, C. Pratley, R.E. (1999) Fasting and postprandial plasma concentrations of acylation-stimulation protein (ASP) in lean and obese Pima Indians compared to Caucasians. Obesity Research, 7, 444 452.
15. Yesilova, Z., Ozata, M., Oktenli, C. et al. (2005) Increased acylation stimulating protein concentrations in nonalcoholic fatty liver disease are associated with insulin resistance. The American Journal of Gastroenterology, 100, 842 849.
16. Ozata, M., Gungor, D., Turan, M. et al. (2001) Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects. Journal of Clinical Endocrinology and Metabolism, 86, 3659 3664.
17. Yang, Y., Lu, H.L., Zhang, J. et al. (2006) Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. International Journal of Obesity, 30, 439 446.
18. Oktenli, C., Ozgurtas, T., Dede, M. et al. (2007) Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome. Gynecological Endocrinology, 23, 710 715.
19. Wu, Y., Zhang, J., Wen, Y. et al. (2009) Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertility and Sterility, 91, 213 219.
20. Tang, J.H., Wen, Y., Wu, F. et al. (2008) Increased plasma acylation-stimulating protein in pediatric proteinuric renal disease. Pediatric Nephrology, 23, 959 964.
21. Cianflone, K., Zakarian, R., Couillard, C. et al. (2004) Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. Journal of Lipid Research, 45, 124 131.
22. Kalant, D., Phelis, S., Fielding, B.A. et al. (2000) Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. Journal of Lipid Research, 41, 1963 1968.
23. Saleh, J., Summers, L.K., Cianflone, K. et al. (1998) Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. Journal of Lipid Research, 39, 884 891.
24. Fujita, T., Fujioka, T., Murakami, T. et al. (2007) Chylomicron accelerates C3 tick-over by regulating the role of factor H, leading to overproduction of acylation stimulating protein. Journal of Clinical Laboratory Analysis, 21, 14 23.
25. Scantlebury, T., Maslowska, M. Cianflone, K. (1998) Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. Journal of Biological Chemistry, 273, 20903 20909.
26. Maslowska, M., Scantlebury, T., Germinario, R. et al. (1997) Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. Journal of Lipid Research, 38, 1 11.
27. Karelis, A.D., Faraj, M., Bastard, J.P. et al. (2005) The metabolically healthy but obese individual presents a favorable inflammation profile. Journal of Clinical Endocrinology and Metabolism, 90, 4145 4150.
28. Friedewald, W.T., Levy, R.I. Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499 502.
29. Matthews, D.R., Hosker, J.P., Rudenski, A.S. et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412 419.
30. Schoeller, D.A. van Santen, E. (1982) Measurement of energy expenditure in humans by doubly labeled water method. Journal of Applied Physiology, 53, 955 959.
31. Maslowska, M., Sniderman, A.D., Germinario, R. et al. (1997) ASP stimulates glucose transport in cultured human adipocytes. International Journal of Obesity and Related Metabolic Disorders, 21, 261 266.
32. Tahiri, Y., Karpe, F., Tan, G.D. et al. (2007) Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics. Annals of Nutrition and Metabolism, 4, 11.
33. Schrauwen, P., Hesselink, M.K., Jain, M. et al. (2005) Acylation-stimulating protein: effect of acute exercise and endurance training. International Journal of Obesity, 29, 632 638.
34. Weyer, C., Tataranni, P.A. Pratley, R.E. (2000) Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration. Diabetes Care, 23, 779 785.
35. Malita, F.M., Karelis, A.D., St-Pierre, D.H. et al. (2006) Surrogate indexes vs. euglycaemic-hyperinsulinaemic clamp as an indicator of insulin resistance and cardiovascular risk factors in overweight and obese postmenopausal women. Diabetes Metabolism, 32, 251 255.
36. Pontiroli, A.E., Pizzocri, P., Caumo, A. et al. (2004) Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study. Acta Diabetologica, 41, 70 76.
37. Ferrara, C.M. Goldberg, A.P. (2001) Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance. Diabetes Care, 24, 245 249.
38. Ikeda, Y., Suehiro, T., Nakamura, T. et al. (2001) Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocrine Journal, 48, 81 86.
39. Muniyappa, R., Lee, S., Chen, H. et al. (2008) Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. American Journal of Physiological Endocrinology and Metabolism, 294, E15 E26.
40. Tripathy, D., Almgren, P., Tuomi, T. et al. (2004) Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. Diabetes Care, 27, 2204 2210.
41. Nugent, C. Younossi, Z.M. (2007) Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nature Clinical Practice. Gastroenterology and Hepatology, 4, 432 441.
42. Jaskiewicz, K., Rzepko, R. Sledzinski, Z. (2008) Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2. Digestive Diseases and Sciences, 53, 785 788.
43. Angulo, P., Hui, J.M., Marchesini, G. et al. (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology, 45, 846 854.
44. Xia, Z., Stanhope, K.L., Digitale, E. et al. (2004) Acylation-stimulating protein (ASP)/complement C3adesArg deficiency results in increased energy expenditure in mice. Journal of Biological Chemistry, 279, 4051 4057.